Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC

NCT06494943 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Sintilimab
DRUG: IBI110
DRUG: Paclitaxel
DRUG: Cis Platinum
PROCEDURE: Surgery
RADIATION: Adjuvant radiation

Sponsor

Fudan University